Heterogeneity of breast cancer: etiology and clinical relevance
- 25 November 2011
- journal article
- research article
- Published by Springer Nature in Clinical and Translational Oncology
- Vol. 13 (11) , 767-773
Abstract
Cancer progression is a dynamic process of clonal adaptation to changing microenvironments. From the single founder cell until the clinical detection of tumours, there are consecutive clonal expansions and a constant acquisition of genetic and epigenetic alterations, events that contribute to the generation of intra-tumor heterogeneity. In breast cancer intra-tumor heterogeneity can arise from the differentiation of stem-like cells along with the clonal selection during tumor progression, and represents a major challenge for the design of effective therapies. To infer breast cancer progression and its response to particular treatments it is important to understand the origins of the inter- and intra-tumor heterogeneity and the forces that control tumor evolution. Insights about the evolution of breast cancer heterogeneity would contribute to the design of most effective therapeutic strategies to target the tumors at single clon level. This review is intended to give a general overview about the origins of breast cancer heterogeneity and its impact in the clinical management of the disease.Keywords
This publication has 55 references indexed in Scilit:
- Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the BreastCell, 2011
- An increase in cancer stem cell population after primary systemic therapy is a poor prognostic factor in breast cancerBritish Journal of Cancer, 2011
- Genetic Predisposition Directs Breast Cancer Phenotype by Dictating Progenitor Cell FateCell Stem Cell, 2011
- Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell ContentCell, 2010
- Tumor heterogeneity: Causes and consequencesBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2010
- Efficient tumour formation by single human melanoma cellsNature, 2008
- Molecular characterisation of the tumour microenvironment in breast cancerEuropean Journal of Cancer, 2008
- The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem CellsCell, 2008
- ALDH1 Is a Marker of Normal and Malignant Human Mammary Stem Cells and a Predictor of Poor Clinical OutcomeCell Stem Cell, 2007
- Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markersBreast Cancer Research and Treatment, 2005